Applied Physiology

Applied Physiology is a global software company, established in 2004 to develop the next generation of integrated patient monitoring systems that will enhance and accelerate clinical decision making in critical care units.

The global cost of critical care is in the order of $750 billion per year, with over 400,000 ICU beds and over 50 million major surgical procedures. Against this backdrop there is increasing pressure for clinical informatics to improve productivity without compromising the quality and safety of care in acute patient units.

Demand is therefore growing for innovative decision support technologies and acute care informatics that relieve the pressure on healthcare providers while improving patient outcomes.

Advanced haemodynamic monitoring

Applied Physiology’s approach to haemodynamic monitoring enables a systematic approach to cardiovascular management.   Navigator™ is a cardiovascular clinical system which provides a real-time graphical display, showing the therapeutic position of the patient in relation to the desired circulatory state.

This integrated haemodynamic monitoring helps clinicians identify AND titrate cardiovascular therapies appropriately for every patient.

Navigator™ technology is based on sound, physiological, patent-protected mathematical algorithms. A pivotal multi-centre randomized clinical trial was published in 2011

Optimised patient care with global reach

Navigator™ has obtained an ARTG Listing (Australia), CE Marking and FDA 510(k) clearance. A key PCT patent was filed in 2008, with national filings in Europe, US, Canada, Australia, India, S Korea and China.

The software is currently being used for intensive care bedside monitoring in hospitals in Australia, Sweden, The Netherlands and UK.

It also continues to be used as part of an ongoing development program at Monash Medical Centre in Melbourne Australia, where the seminal Navigator™ research was conducted by Prof Geoffrey Parkin.

Navigator cardiovascular monitoring software is available for sale in Europe and Australia.  It will be installed in the first US hospital towards the end of 2012.